Kevin Charles Gorman, Director: Neurocrine Biosciences NBIX Sell · Filed 05/21

Trade details

Type: Insider sale
Amount: $37,824,431.04
Shares · price: 245,088 sh · $154.33 a share
Held after: 511,293 sh
Stock: Neurocrine Biosciences NBIX
Person: Kevin Charles GormanDirector
Trade date: 26/05/19
Filed: 26/05/21
Days to filing: 2 days

Sold 32.4% of holdings

Share of holding sold: 32.4%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 04/19~06/18

Kevin Charles Gorman's recent trades

Kevin Charles GormanDirector
Sell10b5-1 planXencor
Sell10b5-1 plan
Xencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/17
Traded 06/15
Kevin Charles GormanDirector
Planned sale10b5-1 planXencor
Planned sale10b5-1 plan
Xencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/15
Traded 06/15
Kevin Charles GormanDirector
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$38.5M
245,088 sh
$38.5M
Filed 05/19
Traded 05/19
Kevin Charles GormanDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$13.4M
106,322 sh
$13.4M
Filed 25/08/11
Traded 25/08/07
Kevin Charles GormanDirector
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$13.7M
106,322 sh
$13.7M
Filed 25/08/07
Traded 25/08/07